These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22706528)

  • 1. Tuberculous meningoencephalitis in a patient with hairy cell leukemia in complete remission.
    Girardi K; Paviglianiti A; Cirillo M; Bianchi A; Gherardi G; Annibali O; Cerchiara E; Marchesi F; Tomarchio V; Miglio C; Tirindelli M; Onetti Muda A; Avvisati G
    J Clin Exp Hematop; 2012; 52(1):31-4. PubMed ID: 22706528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
    Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
    Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group.
    Tobinai K; Ogura M; Hotta T; Kobayashi Y; Narabayashi M; Suzuki R; Kinoshita T; Kozuru M; Uike N; Ohashi Y
    Jpn J Clin Oncol; 1997 Jun; 27(3):146-53. PubMed ID: 9255268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegfilgrastim prophylaxis for cladribine-induced neutropenia in patients with hairy-cell leukemia.
    Goldschmidt N; Ganzel C; Attias D; Gatt M; Polliack A; Tadmor T
    Acta Haematol; 2014; 132(1):118-21. PubMed ID: 24557414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hairy cell leukemia treated with cladribine].
    Ghanima W; Heldal D; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2002 Apr; 122(11):1094-7. PubMed ID: 12043051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of skin rash in patients with hairy cell leukemia treated with cladribine.
    Ganzel C; Gatt ME; Maly A; Ben-Yehuda D; Goldschmidt N
    Leuk Lymphoma; 2012 Jun; 53(6):1169-73. PubMed ID: 22035415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
    Huynh E; Sigal D; Saven A
    Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wrist tuberculosis in cladribine--induced remission of hairy cell leukosis.
    Panchovska MS; Solakov PT; Anavi BL; Spasov EA; Tokmakova KP
    Folia Med (Plovdiv); 2000; 42(4):37-40. PubMed ID: 15359513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcal meningitis occurring at 19 months after cladribine therapy for hairy cell leukemia.
    Ikpeazu EV; Kaplon MK
    Eur J Haematol; 1998 Oct; 61(4):286-7. PubMed ID: 9820640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone marrow fibrosis during therapy of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral tuberculomas in a patient with hairy cell leukaemia treated with cladribine.
    Fonseca SB; de Oliveira JR; Gonçalves C; Lopes V
    BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 27927706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies.
    Doucette KE; Galbraith PA; Bow EJ; Binda BJ; Rendina A; Embil JM
    J Trauma; 2003 Sep; 55(3):568-70. PubMed ID: 14501907
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-Hodgkin's lymphoma.
    Beksaç M; Arat M; Idilman R
    Cancer; 1999 Jan; 85(1):242-3. PubMed ID: 9921999
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine.
    Seshadri P
    Leuk Res; 2000 Jul; 24(7):637. PubMed ID: 10979762
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycobacterium-avium-intracellulare complex infection following 2-chlorodeoxyadenosine therapy for hairy cell leukaemia.
    Broady R; Roberts S; Hawkins T
    Leuk Lymphoma; 2000 Feb; 36(5-6):639-42. PubMed ID: 10784410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine.
    Tousi B; D'Silva R; Papish S
    Clin Lab Haematol; 2002 Aug; 24(4):259-60. PubMed ID: 12181031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia.
    Dinçol G; Kahraman R
    Am J Hematol; 2006 May; 81(5):387. PubMed ID: 16628737
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose cladribine for symptomatic hairy cell leukaemia.
    Juliusson G; Lenkei R; Tjønnfjord G; Heldal D; Liliemark J
    Br J Haematol; 1995 Mar; 89(3):637-9. PubMed ID: 7734367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
    Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D
    Blood; 1997 Mar; 89(5):1838-9. PubMed ID: 9057674
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.